Technology
Health
Biotechnology

Intellipharmaceutics

$0.216
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.0594 (-22.00%) Today
+$0.0054 (2.56%) After Hours

Why Robinhood?

You can buy or sell IPCI and other stocks, options, ETFs, and crypto commission-free!

About

Intellipharmaceutics International Inc. Common Stock, also called Intellipharmaceutics, is a pharmaceutical company, which engages in the research, development, and manufacture of novel and generic controlled-release and targeted-release oral solid dosage drugs. Read More Its patented Hypermatrix technology is a multidimensional controlled-release drug delivery platform that can be applied to the development of existing and new pharmaceuticals in the areas of neurology, cardiovascular, gastrointestinal tract, diabetes and pain. The company was founded by Isa Odidi and Amina Odidi in 1998 and is headquartered in Toronto, Canada.

Employees
Headquarters
Toronto, Ontario
Founded
1998
Market Cap
4.93M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
557.11K
High Today
$0.265
Low Today
$0.21
Open Price
$0.216
Volume
1.10M
52 Week High
$6.60
52 Week Low
$0.2001

Collections

Technology
Health
Biotechnology
Pharmaceutical
Canada
North America

News

BusinessWireFeb 28

Investors That Purchased Intellipharmaceutics International Inc. (“IPCI”) Securities Listed on the Toronto Stock Exchange May Have an Opportunity to Recover Their Financial Losses

TORONTO--(BUSINESS WIRE)--Morganti & Co., P.C., a cross border shareholder’s rights law firm, has commenced a shareholder class action lawsuit against Intellipharmaceutics International Inc.

608

Earnings

-$0.91
-$0.61
-$0.32
-$0.02
Q2 2017
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Estimated
Actual
Expected Apr 15, After Hours
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.